We screened mitotic kinase small molecule inhibitors against PLK1 (volasertib), Aurora kinase A (alisertib), and CHK1 inhibitor (AZD7762) in human and mouse lung cancer cell lines. The gene discussed is PLK1; the disease is lung cancer.